Tinder Conk — Hermetica Encyclopedia
Mushroom · Mushroom/Fungi

Tinder Conk

Preliminary EvidenceCompound

Hermetica Superfood Encyclopedia

The Short Answer

Fomes fomentarius (the species underlying the Fomes excavatus designation) contains phenolics such as isorhamnetin (2734 µg/g) and kaempferol (351 µg/g), sterols such as ergosterol, and polysaccharides that exert antioxidant, antimicrobial, and antiproliferative effects through radical scavenging, membrane disruption, and apoptosis induction. All documented evidence remains at the in vitro and preclinical stage, with the strongest quantified outcome being DPPH radical scavenging at an EC₅₀ of 114.40 µg/mL and antifungal activity against Epidermophyton floccosum at a MIC of 2 mg/mL; no human clinical trials have been published.

PubMed Studies
7
Validated Benefits
Synergy Pairings
At a Glance
CategoryMushroom
GroupMushroom/Fungi
Evidence LevelPreliminary
Primary KeywordFomes excavatus benefits
Fomes excavatus close-up macro showing natural texture and detail — rich in antioxidant, antimicrobial, neuroprotective
Tinder Conk — botanical close-up

Health Benefits

**Antioxidant Protection**: Phenolics, flavonoids, and carotenoids
including isorhamnetin (2734 µg/g), β-carotene (0.59 mg/g dme), and lycopene (0.19 mg/g dme) — donate electrons and hydrogen atoms to neutralize reactive oxygen species, demonstrated by DPPH EC₅₀ of 114.40 µg/mL and β-carotene bleaching inhibition EC₅₀ of 174.50 µg/mL in vitro.
**Antimicrobial Activity**
Hot water and ethanol extracts show broad-spectrum activity against seven tested pathogens; minimum inhibitory concentrations range from 2 mg/mL against Epidermophyton floccosum to 26.67 mg/mL against Aspergillus fumigatus, attributed to membrane disruption and enzyme inhibition by phenolic acids and terpenoids.
**Antiproliferative / Potential Anticancer Effects**
Optimized extracts demonstrate suppression of proliferation across three cancer cell lines at 100–200 µg/mL in vitro, with ergosterol and phenolic flavonoids implicated in inducing apoptosis or cell-cycle arrest, though cell lines and quantitative effect sizes have not been fully disclosed in available reports.
**Neuroprotective Potential**
Phenolics and terpenoids present in the fruiting body inhibit acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) in vitro, suggesting a cholinergic mechanism that could theoretically support cognitive function, although no animal or human validation exists.
**Hemostatic and Wound-Healing Support**
Traditional and historical applications document styptic (blood-stopping) properties attributed to the highly absorbent, fibrous amadou tissue of the fruiting body; anti-inflammatory triterpenes may additionally support tissue repair at wound sites.
**Anti-Inflammatory Action**
Triterpenoids and sterols, including ergosta-7,22-dien-3β-ol (1.43%) and ergosterol (2.27%), are proposed to modulate inflammatory pathways by inhibiting pro-inflammatory enzyme cascades, consistent with the primary categorized use of this ingredient as a source of anti-inflammatory triterpenoids.
**Ferric-Reducing / Redox Modulation**
Ferric reducing antioxidant power measured at EC₅₀ of 250.70 µg/mL indicates meaningful electron-donating capacity that may reduce oxidative stress-driven cellular damage, complementing radical scavenging mechanisms from total phenolics quantified at 75.83 mg GAE/g dry matter extract.

Origin & History

Fomes excavatus growing in Africa — natural habitat
Natural habitat

Fomes fomentarius — the species most consistently associated with the name Fomes excavatus in the literature — is a perennial bracket polypore fungus distributed across temperate forests of Europe, North Africa (Morocco, Tunisia), Asia, and North America, typically parasitizing and decaying hardwood trees such as birch, beech, and oak. It produces distinctive hoof-shaped, woody fruiting bodies that persist for multiple years and are harvested from tree trunks throughout the year. Cultivation via submerged fermentation and solid-state methods has been explored to generate standardized biomass for research and potential commercial use.

Fomes fomentarius has one of the longest documented relationships between humans and fungi, with archaeological evidence — including its presence among the possessions of Ötzi the Iceman (c. 3300 BCE) — indicating its use as tinder and likely as a medicinal material for thousands of years. Across European, North African, Russian, and Chinese folk medicine traditions, the amadou (inner fibrous layer) was applied topically as a styptic to arrest bleeding, as a wound dressing, and as a cauterizing agent, while decoctions were used internally as general tonics and for gastrointestinal complaints. In some Central European traditions the fruiting body was also fashioned into felt-like material for clothing and pouches, reflecting its cultural importance beyond purely medicinal contexts. Moroccan and Tunisian ethnobotanical records confirm contemporary informal use of this polypore for antimicrobial and anti-inflammatory purposes, providing the cultural backdrop for modern phytochemical investigations.Traditional Medicine

Scientific Research

The current evidence base for Fomes fomentarius (Fomes excavatus) consists entirely of in vitro and analytical chemistry studies; no peer-reviewed human clinical trials or controlled animal intervention studies with full efficacy endpoints have been published in accessible literature as of the most recent search. Quantified bioactivity data derive from a small number of extraction and characterization studies — primarily Moroccan and Tunisian sample sets — that report EC₅₀ values, MIC determinations, and antiproliferative observations in unspecified cancer cell lines without formal sample sizes or statistical power calculations. Response-surface methodology (RSM) optimization studies demonstrate that extraction conditions meaningfully alter phenolic yield and downstream bioactivity, introducing substantial variability across reports and limiting direct comparison. The overall evidence quality is preclinical and exploratory; while the bioactive compound profile is well-characterized analytically, therapeutic efficacy, effective doses, and safety in humans remain entirely unestablished.

Preparation & Dosage

Fomes excavatus steeped as herbal tea — pairs with Fomes fomentarius extracts may exhibit additive or synergistic antimicrobial effects when combined with other phenolic-rich fungi such as Ganoderma lucidum, which shares triterpenoid and beta-glucan constituents that operate through complementary membrane-disruption and immune-modulating mechanisms. The ergosterol content suggests potential synergy with vitamin D₂ supplementation under UV-activation conditions, and
Traditional preparation
**Hot Water Decoction (Traditional)**
Fruiting bodies dried, sliced, and simmered in water; no standardized dose established — historically consumed as a tea or topical wash for wound care and hemostasis.
**Ethanol/Hydroalcoholic Extract (Research-Grade)**
Extraction yields approximately 7.59% dry weight; in vitro studies employ 100–200 µg/mL concentrations, but no human equivalent dose has been calculated or validated.
**RSM-Optimized Extract**
75 mg GAE/g dme); considered superior to simple maceration for bioactive enrichment
Response surface methodology with optimized temperature, time, and solvent ratios produces elevated total phenolics (>.
**Submerged Cultivation Biomass**
Mycelial biomass generated via liquid fermentation provides a potentially standardizable raw material; no commercial standardization percentage (e.g., % triterpenoids or beta-glucans) has been established for this species.
**Standardization Status**
No pharmacopeial monograph or accepted standardization for isorhamnetin, ergosterol, or total phenolic content exists for this fungus; any commercial preparation should be regarded as non-standardized until validated.
**Timing/Administration Notes**
Bioavailability of phenolics and triterpenoids is typically low without specialized delivery (e.g., nanoparticle encapsulation); optimal administration timing relative to meals is unknown.

Nutritional Profile

Fomes fomentarius fruiting bodies provide a complex matrix rather than a conventional nutritional profile: polysaccharides (including beta-glucans) represent the dominant structural component, with sugars accounting for approximately 64.63% of the derivatized GC-MS extract fraction. Fatty acids constitute approximately 14.72% of the same extract, with profiles typical of fungal tissue (oleic, linoleic, and palmitic acids). Sterols — notably ergosterol (2.27%) and ergosta-7,22-dien-3β-ol (1.43%) — serve as ergocalciferol (vitamin D₂) precursors upon UV irradiation, a recognized nutritional feature of edible and medicinal fungi. Organic acids (e.g., malic acid 1.87%) and alcohols (10 identified compounds) contribute to the metabolite profile; total phenolics reach 75.83 mg GAE/g dry matter extract and total flavonoids 37.62 mg CE/g dme, classifying this as a phenolic-rich functional material. Bioavailability of these constituents in humans is unstudied for this species, though polyphenol oral absorption is generally low (typically <10%) without formulation enhancement, and beta-glucans require gut microbiota fermentation for partial utilization.

How It Works

Mechanism of Action

The primary antioxidant mechanism involves hydrogen-atom and electron transfer by isorhamnetin, kaempferol, and p-hydroxybenzoic acid to quench superoxide, hydroxyl, and peroxyl radicals, with DPPH scavenging (EC₅₀ 114.40 µg/mL) and ferric reduction (EC₅₀ 250.70 µg/mL) serving as validated in vitro proxies for this activity. Antimicrobial effects are attributed to phenolic acids and terpenoids disrupting microbial membrane integrity and inhibiting key microbial enzymes, producing concentration-dependent growth inhibition (MIC 2–26.67 mg/mL across seven pathogens). Ergosterol and related Δ7-sterols may exert antiproliferative effects by interfering with mammalian cell membrane cholesterol dynamics or triggering intrinsic apoptotic signaling, while polysaccharides (beta-glucans) are broadly recognized in polypore fungi to modulate macrophage activation via Toll-like receptor (TLR-2/Dectin-1) engagement, enhancing innate immune cytokine output. Cholinesterase inhibition by phenolic and terpenoid constituents is proposed to reduce acetylcholine hydrolysis at neuronal synapses, offering a preliminary mechanistic rationale for neuroprotective claims that remain unconfirmed in vivo.

Clinical Evidence

No human clinical trials investigating Fomes fomentarius or Fomes excavatus for any indication have been identified in available literature. All reported outcomes originate from cell-free radical scavenging assays, microbial growth inhibition assays, and unspecified cancer cell-line proliferation experiments conducted at extract concentrations of 100–200 µg/mL in vitro. Effect sizes from these assays — DPPH EC₅₀ 114.40 µg/mL, antimicrobial MIC range 2–26.67 mg/mL — cannot be extrapolated to clinical doses without pharmacokinetic and bioavailability data, which are absent. Confidence in clinical benefit is therefore very low, and this ingredient should be regarded as a candidate for further preclinical and eventually Phase I investigation rather than an evidence-based therapeutic agent.

Safety & Interactions

No formal human toxicology studies, adverse event reports, or dose-escalation trials have been conducted for Fomes fomentarius or Fomes excavatus; the absence of safety data means that neither a no-observed-adverse-effect level (NOAEL) nor a maximum tolerated dose can be stated. The antiproliferative activity observed in cancer cell lines at 100–200 µg/mL in vitro introduces a theoretical caution for individuals with hormone-sensitive conditions or those undergoing chemotherapy, as interactions with cytotoxic drug metabolism via CYP450 enzyme modulation by phenolics cannot be excluded. Hemostatic (styptic) properties described historically suggest potential pharmacodynamic interaction with anticoagulant or antiplatelet medications (e.g., warfarin, clopidogrel), warranting avoidance until interaction studies are performed. Guidance for use during pregnancy or lactation cannot be provided due to complete absence of reproductive toxicology data, and use in these populations should be avoided pending further research.

Synergy Stack

Hermetica Formulation Heuristic

Also Known As

Tinder Conk (Fomes fomentarius)Fomitopsis fomentariusTinder ConkTinder PolyporeFomes fomentariusIce Man FungusHoof FungusAmadou Mushroom

Frequently Asked Questions

What are the main bioactive compounds in Fomes excavatus?
Fomes excavatus is associated with Fomes fomentarius, whose key bioactive compounds include isorhamnetin (2734 µg/g), kaempferol (351 µg/g), p-hydroxybenzoic acid (409 µg/g), ergosterol (2.27%), and beta-glucan polysaccharides. Total phenolics reach 75.83 mg GAE/g dry matter extract and total flavonoids 37.62 mg CE/g, making phenolics and triterpenoids the primary pharmacologically active fractions.
Is there any clinical trial evidence supporting Fomes fomentarius for inflammation or other conditions?
No human clinical trials have been published for Fomes fomentarius or Fomes excavatus; all available evidence is limited to in vitro assays, including antioxidant EC₅₀ measurements, microbial inhibition tests, and cancer cell-line proliferation experiments. The anti-inflammatory triterpenoid activity identified in laboratory studies has not been validated in animal models or human subjects, so therapeutic claims cannot currently be substantiated.
What is the traditional use of Fomes fomentarius (tinder conk)?
Fomes fomentarius has been used in folk medicine for at least 5,000 years — evidenced by its discovery with Ötzi the Iceman — primarily as a topical hemostatic agent to stop bleeding from wounds, leveraging the highly absorbent amadou tissue. It has also been employed in European, North African, and Asian traditional medicine as an antimicrobial wound dressing and as a decoction for gastrointestinal and inflammatory complaints.
What dose of Fomes fomentarius extract is used in research?
Research studies employ crude ethanol or hot-water extracts at in vitro concentrations of 100–200 µg/mL for antiproliferative and antioxidant assessments, with an extraction yield of approximately 7.59% from dried fruiting bodies. No standardized human supplemental dose exists; pharmacokinetic data translating in vitro concentrations to oral doses are entirely absent, making evidence-based dosing recommendations impossible at this time.
Is Fomes excavatus safe to take as a supplement?
No formal human safety or toxicology data exist for Fomes excavatus or Fomes fomentarius, meaning neither safety nor dosing thresholds have been established. Theoretical concerns include interactions with anticoagulant drugs due to historical hemostatic properties, and potential interactions with chemotherapy given in vitro antiproliferative effects; pregnant or breastfeeding individuals should avoid use until reproductive safety is studied.
How does Fomes excavatus compare to other medicinal mushrooms for antioxidant protection?
Fomes excavatus demonstrates potent antioxidant activity with a DPPH EC₅₀ of 114.40 µg/mL, placing it among stronger antioxidant mushrooms, though direct head-to-head comparisons with species like reishi or cordyceps are limited in the literature. Its unique combination of isorhamnetin (2734 µg/g), β-carotene (0.59 mg/g dme), and lycopene (0.19 mg/g dme) provides a diverse polyphenolic and carotenoid profile. The β-carotene bleaching inhibition assay (EC₅₀ 174.50 µg/mL) specifically validates its capacity to protect against lipid peroxidation, a mechanism particularly relevant for cardiovascular and neurological health.
What extraction method produces the most effective Fomes fomentarius supplement?
Hot water extraction is traditionally favored and shows significant antimicrobial and antioxidant activity, making it suitable for capturing both water-soluble polysaccharides and heat-stable phenolics. Ethanol extraction has also demonstrated bioactivity in research, though the optimal extraction solvent depends on the specific bioactive compounds targeted—hot water is preferred for immune-supporting polysaccharides while ethanol may extract higher flavonoid concentrations. Dual-extraction methods combining hot water and ethanol may offer complementary bioactive profiles for comprehensive biological activity.
Who should consider Fomes excavatus supplementation based on current research?
Individuals seeking antioxidant and antimicrobial support—particularly those interested in traditional immune-modulating mushrooms or natural alternatives to synthetic antimicrobials—may benefit from Fomes excavatus supplementation. The ingredient's phenolic and carotenoid profile suggests potential relevance for those concerned with oxidative stress-related conditions, though robust clinical evidence in specific populations remains limited. People with documented sensitivity to fungal compounds or mold allergies should exercise caution, as mushroom extracts can trigger cross-reactivity in susceptible individuals.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.